Although the mechanisms by which GAMs migrate to the tumor site are not entirely clear, some studies have shown that their recruitment is mediated by various glioma-derived factors such as CCL2, CX3CL1, SDF-1, CSF-1, GM-CSF and EGF, which act as chemoattractants for GAMs and mediate the crosstalk between tumor cells and the innate immune system [40] (Figure 1). The gene discussed is EGF; the disease is neoplasm.